Novel therapeutic agents for HbF induction: a new era for treatment of β thalassemia?
<p>Fetal globin is endogenous, normally integrated in hematopoietic stem cells in all humans, and available for reactivation. Inducing expression of fetal globin (g-globin) gene expression to 60-70% of a globin synthesis produces β-thalassemia trait globin synthetic ratios, and has be...
Main Author: | S.P. Perrine |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-12-01
|
Series: | Thalassemia Reports |
Subjects: | |
Online Access: | http://www.pagepressjournals.org/index.php/thal/article/view/297 |
Similar Items
-
Closed relationship of βE-allele and high HbF associated cis-loci: Case studies in Thai HbE/ β-thalassemia families
by: Lamplimas Tangpan, et al.
Published: (2015-05-01) -
Therapeutic Relevance of Inducing Autophagy in β-Thalassemia
by: Roberto Gambari, et al.
Published: (2024-05-01) -
Periferik Kanında %100 HbF Bulunan Talasemi İntermedia Olgusu
by: Ayşegül Uğur Kurtoğlu, et al.
Published: (2021-06-01) -
Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective
by: Rayan Bou-Fakhredin, et al.
Published: (2022-06-01) -
Genetic modifications of EGLN1 reactivate HbF production in β0-thalassemia/HbE
by: Varit Jan-ngam, et al.
Published: (2024-09-01)